Lymphoproliferative lesions of the skin

Journal of Clinical Pathology

Volumn 59, Issue 8, 2006, Pages 813-826

  Cerroni, L ^a  

^a Universitatsklinik fur Dermatologie und Venerologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN;

ANTIGEN EXPRESSION; B CELL LYMPHOMA; CANCER CLASSIFICATION; CLINICAL FEATURE; CUTANEOUS T CELL LYMPHOMA; DIAGNOSTIC PROCEDURE; DISEASE CLASSIFICATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MYCOSIS FUNGOIDES; NATURAL KILLER CELL; PANNICULITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SKIN LYMPHOMA; T CELL LYMPHOMA;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA; LYMPHOMA, B-CELL; LYMPHOMA, T-CELL, CUTANEOUS; MYCOSIS FUNGOIDES; SKIN NEOPLASMS;

EID: 33747060477     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.033019     Document Type: Review

References (49)

1. Willemze R, Jaffe ES, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood 2005;105:3768-85.
2. Fink-Puches R, Zenahlik P, Böck B, et al. Primary cutaneous lymphomas: applicability of current classification schemes (EORTC, WHO) based on clinicopathologic features observed in a large group of patients. Blood 2002;99:800-5.
3. Cerroni L, Gatter K, Kerl H. An illustrated guide to skin lymphoma 2nd edn. Maiden: Blackwell Publishing, 2004.
4. Massone C, Kodama K, Kerl H, et al. Histopathologic features of early (patch) lesions of mycosis fungoides. A morphologic study on 745 biopsy specimens from 427 patients. Am J Surg Pathol 2005;29:550-60.
5. Ming M, LeBoit PE. Can dermatopathologists reliably make the diagnosis of mycosis fungoides? If not, who can? Arch Dermatol 2000;136:543-46.
6. Santucci M, Biggeri A, Feller AC, et al. Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma. Arch Dermatol 2000;136:497-502.
7. Santucci M, Biggeri A, Feller AC, et al. Efficacy of histologic criteria for diagnosing early mycosis fungoides. An EORTC Cutaneous Lymphoma Study Group investigation. Am J Surg Pathol 2000;24:40-50.
8. Vonderheid EC, Bernengo MG, Burg G, et al. Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol 2002;46:95-106.
9. Sanchez JL, Ackerman AB. The patch stage of mycosis fungoides. Criteria for histologie diagnosis. Am J Dermatopathol 1979;1:5-26.
10. Shapiro PE, Pinto FJ. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes. Am J Surg Pathol 1994;18:645-67.
11. Wain EM, Orchard GE, Mayou S, et al. Mycosis fungoides with a CD56+ immunophenotype. J Am Acad Dermatol 2005;53:158-63.
12. Cerroni L, Arzberger E, Ardigo M, et al. Monoclonality of intraepidermal T lymphocytes in early mycosis fungoides detected by molecular analysis after laser-beam-based microdissection. J Invest Dermatol 2000;114:1154-7.
13. Yazdi AS, Medeiros LJ, Puchta U, et al. Improved detection of clonality in cutaneous T-cell lymphomas using laser capture microdissection. J Cut Pathol 2003;30:486-91.
14. Tracey L, Villuendas R, Dotor AM, et al. Mycosis fungoides shows concurrent deregulation of multiple genes involved in the TNF signaling pathway: an expression profile study. Blood 2003;102:1042-50.
15. Cerroni L, Fink-Puches R, Bäck B, et al. Follicular mucinosis. A critical reappraisal of clinicopathologic features and association with mycosis fungoides and Sézary syndrome. Arch Dermatol 2002;138:182-9.
16. Diwan AH, Prieto VG, Herling M, et al. Primary Sézary syndrome commonly shows low-grade cytologic atypia and an absence of epidermotropism. Am J Clin Pathol 2005;123:510-5.
17. El Shabrawi-Caelen L, Kerl H, Cerroni L. Lymphomatoid papulosis. Reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C. Arch Dermatol 2004;140:441-7.
18. Leinweber B, Kerl H, Cerroni L. Histopathologic features of cutaneous herpes virus infections (herpes simplex, herpes varicella/zoster): a broad spectrum of presentations with common pseudolymphomatous aspects. Am J Surg Pathol 2006;30:50-8.
19. Hinshaw M, Trowers AB, Kodish E, et al. Three children with CD30+ cutaneous anaplastic large cell lymphomas bearing the t(2;5)(q23;q35) translocation. Ped Dermatol 2004;21:212-7.
20. Massone C, Chott A, Metze D, et al. Subcutaneous, blastic natural killer (NK), NK/T-cell, and other cytotoxic lymphomas of the skin. A morphologic, immunophenotypic, and molecular study of 50 patients. Am J Surg Pathol 2004;28:719-35.
21. Massone C, Lozzi GP, Egberts F, et al. The protean spectrum of non-Hodgkin lymphomas with prominent involvement of subcutaneous fat. J Cut Pathol 2006;33:418.
22. Massone C, Kodama K, Salmhofer W, et al. Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases. J Cut Pathol 2005;32:396-404.
23. Lozzi GP, Massone C, Citarella L, et al. Rimming of adipocytes by neoplastic lymphocytes is a histopathologic feature not restricted to subcutaneous T-cell lymphoma. Am J Dermatopathol 2006;28:9-12.
24. Cerroni L, Signoretti S, Höfler G, et al. Primary cutaneous marginal zone B-cell lymphoma: a recently described entity of low-grade malignant cutaneous B-cell lymphoma. Am J Surg Pathol 1997;21:1307-15.
25. Leinweber B, Colli C, Chott A, et al. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern. Am J Dermatopathol 2004;26:4-13.
26. Cerroni L, Zöchling N, Pütz B, et al. Infection by Borrelia burgdorferi and cutaneous B-cell lymphoma. J Cut Pathol 1997;24:457-61.
27. Goodlad JR, Davidson MM, Hollowood K, et al. Primary cutaneous B-cell lymphoma and Borrelia burgdorferi infection in patients from the highlands of Scotland. Am J Surg Pathol 2000;24:1279-85.
28. Streubel B, Lamprecht A, Dierlamm J, et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. Blood 2003;101:2335-9.
29. Streubel B, Simonitsch-Klupp I, Müllouer L, et al. Variable frequencies of MALT lymphoma-associatea genetic aberrations in MALT lymphomas of different sites. Leukaemia 2004;18:1722-6.
30. Cerroni L, Arzberger E, Pütz B, et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. Blood 2000;95:3922-8.
31. Cerroni L, Volkenandt M, Rieger E, et al. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994;102:231-5.
32. Goodlad JR, Krajewski AS, Batstone PJ, et al. Primary cutaneous follicular lymphoma. A clinicopathologic and molecular study of 16 cases in support of a distinct entity. Am J Surg Pathol 2002;26:733-41.
33. Kim BK, Surti U, Pandya A, et al. Clinicopathologic, immunophenotypic, and molecular cytogenetic fluorescence in situ hybridization analysis of primary and secondary cutaneous follicular lymphomas. Am J Surg Pathol 2005;29:69-82.
34. Kodama K, Massone C, Chott A, et al. Primary cutaneous large B-cell lymphomas: clinicopathologic features, classification, and prognostic factors in a large series of patients. Blood 2005;106:2491-7.
35. Colli C, Leinweber B, Müllegger R, et al. Borrelia burgdorferi-associated lymphocytoma cutis: clinicopathologic, immunophenotypic, and molecular study of 106 cases. J Cut Pathol 2004;31:232-40.
36. Grange F, Wechsler J, Guillaume JC, et al. Borrelia burgdorferi- associated lymphocytoma cutis simulating a primary cutaneous large B-cell lymphoma. J Am Acad Dermatol 2002;47:530-4.
37. Cerroni L, El-Shabrawi-Caelen L, Fink-Puches R, et al. Cutaneous spindle-cell B-cell lymphoma. A morphologic variant of cutaneous large B-cell lymphoma. Am J Dermatopathol 2000;22:299-304.
38. Hoefnagel JJ, Dijkman R, Basso K, et al. Distinct types of primary cutaneous large B-cell lymphoma identified by gene expression profiling. Blood 2005;105:3671-8.
39. Vermeer MH, Geelen FAMJ, van Haselen CW, et al. Primary cutaneous large B-cell lymphomas of the legs. A distinct type of cutaneous B-cell lymphoma with an intermediate prognosis. Arch Dermatol 1996;132:1304-8.
40. Grange F, Petrella T, Beylot-Barry M, et al. Bcl-2 protein expression is the strongest independent prognostic factor of survival in primary cutaneous large B-cell lymphomas. Blood 2004;103:3662-8.
41. Grange F, Bekkenk MW, Wechsler J, et al. Prognostic factors in primary cutaneous large B-cell lymphomas: a European multicenter study of 145 cases. J Clin Oncol 2001;19:3602-10.
42. Wiesner T, Streubel B, Huber D, et al. Genetic aberrations in primary cutaneous large B-cell lymphoma. A fluorescence in situ hybridization study of 25 cases. Am J Surg Pathol 2005;29:666-73.
43. Jaffe ES, Harris NL, Stein H, Vardiman JW, eds. World Health Organization Classification of Tumours. Tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2001.
44. Cerroni L, Zalaudek I, Kerl H. Intravascular large B-cell lymphoma colonizing cutaneous hemangiomas. Dermatology 2004;209:132-4.
45. Cerroni L. Hemangiomas with a bad surprise. Dermatology 2004;209:79-80.
46. Cerroni L, Zenahlik P, Höfler G, et al. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukaemia. A clinicopathologic and prognostic study of 42 patients. Am J Surg Pathol 1996;20:1000-10.
47. Cerroni L, Zenahlik P, KeH H. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukaemia arising at the site of herpes zoster and herpes simplex scars. Cancer 1995;76:26-31.
48. Cerroni L, Höfler G, Bäck B, et al. Specific cutaneous infiltrates of B-cell chronic lymphocytic leukaemia (B-CLL) at sites typical for Borrelia burgdorferi infection. J Cut Pathol 2002;29:142-7.
49. Chimenti S, Fink-Puches R, Peris K, et al. Cutaneous involvement in lymphoblastic lymphoma. J Cut Pathol 1999;26:379-85.